
The international market for drugs against the skin disease psoriasis will annually grow by 6.8 percent on average by 2030, when the market will total USD 27.5bn, UK-based analytics firm Globaldata reports in a press release.
Seven of the biggest markets have been included in the assessment: US, France, Germany, Italy, Spain, UK and Japan.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app